These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3718378)

  • 1. Effect of spironolactone on acute mountain sickness.
    Larsen RF; Rock PB; Fulco CS; Edelman B; Young AJ; Cymerman A
    Aviat Space Environ Med; 1986 Jun; 57(6):543-7. PubMed ID: 3718378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of spironolactone in the prevention of acute mountain sickness on Kilimanjaro.
    Brookfield DS; Liston WA; Brown GV
    East Afr Med J; 1977 Dec; 54(12):689-91. PubMed ID: 612430
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of acute mountain sickness by dexamethasone.
    Johnson TS; Rock PB; Fulco CS; Trad LA; Spark RF; Maher JT
    N Engl J Med; 1984 Mar; 310(11):683-6. PubMed ID: 6700643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexamethasone on symptoms of acute mountain sickness at Pikes Peak, Colorado (4,300 m).
    Rock PB; Johnson TS; Cymerman A; Burse RL; Falk LJ; Fulco CS
    Aviat Space Environ Med; 1987 Jul; 58(7):668-72. PubMed ID: 3619842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone and acute mountain sickness.
    Currie TT; Carter PH; Champion WL; Fong G; Francis JK; McDonald IH; Newing RK; Nunn IN; Sisson RN; Sussex M; Zacharin RF
    Med J Aust; 1976 Jul; 2(5):168-70. PubMed ID: 979834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone in the treatment of acute mountain sickness.
    Levine BD; Yoshimura K; Kobayashi T; Fukushima M; Shibamoto T; Ueda G
    N Engl J Med; 1989 Dec; 321(25):1707-13. PubMed ID: 2687688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group).
    Basnyat B; Holck PS; Pun M; Halverson S; Szawarski P; Gertsch J; Steif M; Powell S; Khanal S; Joshi A; Shankar R; Karambay J; Alexander HD; Stone A; Morrissey C; Thompson BH; Farrar J;
    Wilderness Environ Med; 2011 Mar; 22(1):15-22. PubMed ID: 21377114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin: ineffective against acute mountain sickness.
    Burse RL; Landowne M; Young AJ; Maher JT
    Aviat Space Environ Med; 1982 Mar; 53(3):221-5. PubMed ID: 6764869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide in control of acute mountain sickness.
    Lancet; 1981 Jan; 1(8213):180-3. PubMed ID: 6109857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeping in moderate hypoxia at home for prevention of acute mountain sickness (AMS): a placebo-controlled, randomized double-blind study.
    Dehnert C; Böhm A; Grigoriev I; Menold E; Bärtsch P
    Wilderness Environ Med; 2014 Sep; 25(3):263-71. PubMed ID: 24931591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone as prophylaxis for acute mountain sickness. Effect of dose level.
    Rock PB; Johnson TS; Larsen RF; Fulco CS; Trad LA; Cymerman A
    Chest; 1989 Mar; 95(3):568-73. PubMed ID: 2920585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone and acute mountain sickness.
    Snell JA; Cordner EP
    Med J Aust; 1977 May; 1(22):828. PubMed ID: 887008
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes.
    Montgomery AB; Luce JM; Michael P; Mills J
    JAMA; 1989 Feb; 261(5):734-6. PubMed ID: 2911170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone in acute mountain sickness.
    Lancet; 1977 Apr; 1(8016):855. PubMed ID: 67358
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation.
    Larson EB; Roach RC; Schoene RB; Hornbein TF
    JAMA; 1982 Jul; 248(3):328-32. PubMed ID: 7045433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine does not prevent acute mountain sickness.
    Hohenhaus E; Niroomand F; Goerre S; Vock P; Oelz O; Bärtsch P
    Am J Respir Crit Care Med; 1994 Sep; 150(3):857-60. PubMed ID: 8087361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteinyl leukotriene blockade does not prevent acute mountain sickness.
    Muza SR; Kaminsky D; Fulco CS; Banderet LE; Cymerman A
    Aviat Space Environ Med; 2004 May; 75(5):413-9. PubMed ID: 15152893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech motor control and acute mountain sickness.
    Cymerman A; Lieberman P; Hochstadt J; Rock PB; Butterfield GE; Moore LG
    Aviat Space Environ Med; 2002 Aug; 73(8):766-72. PubMed ID: 12182216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent.
    Gertsch JH; Seto TB; Mor J; Onopa J
    High Alt Med Biol; 2002; 3(1):29-37. PubMed ID: 12006162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID).
    Lipman GS; Kanaan NC; Phillips C; Pomeranz D; Cain P; Fontes K; Higbee B; Meyer C; Shaheen M; Wentworth S; Walsh D
    High Alt Med Biol; 2015 Jun; 16(2):154-61. PubMed ID: 25950723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.